Moderate Weight Loss Improves Health in Obese Patients with Diabetes

Published Online: Wednesday, August 7, 2013
Follow Pharmacy_Times:
Modest weight loss may provide long-term health benefits to obese patients with type 2 diabetes, according to new research presented on June 24, 2013, at the American Diabetes Association’s annual scientific meeting.

Researchers worked with 5145 obese diabetes patients, half of whom were assigned to an intensive diet and exercise program in which they attended individual and group meetings and were taught strategies for weight loss. The other half received a general program of diabetes education and support several times a year.

Patients in the intensive diet and exercise group lost ~8.6% of their starting weight after 1 year and maintained a 6% weight loss at the end of the 10-year study. Those in the general education group lost 1% of their weight within the first year and 3.5% by the end of the study. Compared with those in the education group, those in the intensive group had improved hemoglobin A1C levels, had higher HDL levels, and took less diabetes medication. Participants in the intensive group were also 31% less likely to develop chronic kidney disease than those in the education group.


Related Articles
The FDA today approved dulaglutide (Trulicity), a once-weekly injectable therapy indicated to improve blood sugar control in adults with type 2 diabetes.
Combined with bolus insulin aspart (NovoLog), insulin degludec (Tresiba) improves long-term glycemic control in children and adolescents with type 1 diabetes.
Results show pharmacists and other healthcare providers can work together to successfully empower patients disproportionately affected by diabetes to achieve improved clinical outcomes.
Latest Issues
$auto_registration$